Regulatory T-cells protect from type 1 diabetes after induction by coxsackievirus infection in the context of transforming growth factor-β

Diabetes

Volumn 57, Issue 5, 2008, Pages 1302-1311

  Richer, Martin J ^a   Straka, Nadine ^a   Fang, Dianne ^a   Shanina, Iryna ^a   Horwitz, Marc S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA; RECOMBINANT PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; COXSACKIE VIRUS INFECTION; DIABETOGENESIS; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE; MACROPHAGE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SINGLE DRUG DOSE; UPREGULATION; ANIMAL; DISEASE MODEL; FLOW CYTOMETRY; GENETICS; HUMAN; IMMUNOLOGY; TRANSGENIC MOUSE; VIROLOGY;

ANIMALS; COXSACKIEVIRUS INFECTIONS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HUMANS; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; RECOMBINANT PROTEINS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 48449089249     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1460     Document Type: Article

References (45)

1. Jun HS, Yoon JW: A new look at viruses in type 1 diabetes. Diabete Metab Res Rev 19:8-31, 2003
2. Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA: Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 49:708-711, 2000
3. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N: Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 4:781-785, 1998
4. Anderson MS, Bluestone JA: The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23:447-485, 2005
5. Chen W, Wahl SM: TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression. Cytokine Growth Factor Rev 14:85-89, 2003
6. Nakamura K, Kitani A, Strober W: Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194:629-644, 2001
7. You S, Belghith M, Cobbold S, Alyanakian MA, Gouarin C, Barriot S, Garcia C, Waldmann H, Bach JF, Chatenoud L: Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 54:1415-1422, 2005
8. You S, Thieblemont N, Alyanakian MA, Bach JF, Chatenoud L: Transforming growth factor-beta and T-cell-mediated immunoregulation in the control of autoimmune diabetes. Immunol Rev 212:185-202, 2006
9. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM: Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198:1875-1886, 2003
10. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H: Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6:1219-1227, 2005
11. Luo X, Tarbell KV, Yang H, Pothoven K, Bailey SL, Ding R, Steinman RM, Suthanthiran M: Dendritic cells with TGF-beta1 differentiate naive CD4+CD25-T cells into islet-protective Foxp3+ regulatory T cells. Proc Natl Acad SciUSA 104:2821-2826, 2007
12. Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA: Arole for TGF-beta in the generation and expansion of CD4+ CD25+ regulatory T cells from human peripheral blood. J Immunol 166:7282-7289, 2001
13. Fahlen L, Read S, Gorelik L, Hurst SD, Coffman RL, Flavell RA, Powrie F: T cells that cannot respond to TGF-beta escape control by CD4(+ )CD25(+ ) regulatory T cells. J Exp Med 201:737-746, 2005
14. Pop SM, Wong CP, Culton DA, Clarke SH, Tisch R: Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+ CD25+ regulatory T cells during autoimmune diabetes. J Exp Med 201:1333-1346, 2005
15. Peng Y, Laouar Y, Li MO, Green EA, Flavell RA: TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+ CD25+ regulatory T cells responsible for protection against diabetes. Proc Natl Acad SciUSA101:4572-4577, 2004
16. Luo X, Yang H, Kim IS, Saint-Hilaire F, Thomas DA, De BP, Ozkaynak E, Muthukumar T, Hancock WW, Crystal RG, Suthanthiran M: Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice. Transplantation 79:1091-1096, 2005
17. King C, Davies J, Mueller R, Lee MS, Krahl T, Yeung B, O'Connor E, Sarvetnick N: TGF-beta1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity 8:601-613, 1998
18. Richer MJ, Fang D, Shanina I, Horwitz MS: Toll-like receptor 4-induced cytokine production circumvents protection conferred by TGF-beta in coxsackievirus-mediated autoimmune myocarditis. Clin Immunol 121: 339-349, 2006
19. Webb SR, Loria RM, Madge GE, Kibrick S: Susceptibility of mice to group B coxsackie virus is influenced by the diabetic gene. J Exp Med 143:1239-1248, 1976
20. Grewal IS, Grewal KD, Wong FS, Wang H, Picarella DE, Janeway CA Jr, Flavell RA: Expression of transgene encoded TGF-beta in islets prevents autoimmune diabetes in NOD mice by a local mechanism. J Autoimmun 19:9-22, 2002
21. Horwitz MS, Fine C, Ilic A, Sarvetnick N: Requirements for viral-mediated autoimmune diabetes: beta-cell damage and immune infiltration. J Autoimmun 16:211-217, 2001
22. Chen Z, Herman AE, Matos M, Mathis D, Benoist C: Where CD4+CD25 + T reg cells impinge on autoimmune diabetes. J Exp Med 202:1387-1397, 2005
23. Ott PA, Anderson MR, Tary-Lehmann M, Lehmann PV: CD4+ CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes. Cell Immunol 235:1-11, 2005
24. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238, 2006
25. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT: Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441:231-234, 2006
26. Li MO, Wan YY, Flavell RA: T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1-and Th17-cell differentiation. Immunity 26:579-591, 2007
27. Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N: Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J Clin Invest 109:79-87, 2002
28. Kohm AP, McMahon JS, Podojil JR, Begolka WS, DeGutes M, Kasprowicz DJ, Ziegler SF, Miller SD: Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+ CD25+ T regulatory cells. J Immunol 176:3301-3305, 2006
29. Sansom DM, Walker LS: The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol Rev 212:131-148, 2006
30. Zheng SG, Wang JH, Stohl W, Kim KS, Gray JD, Horwitz DA: TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J Immunol 176:3321-3329, 2006
31. Kosiewicz MM, Alard P: Tolerogenic antigen-presenting cells: regulation of the immune response by TGF-beta-treated antigen-presenting cells. Immunol Res 30:155-170, 2004
32. Kosiewicz MM, Alard P, Liang S, Clark SL: Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand. Int Immunol 16:697-706, 2004
33. Horwitz MS, Knudsen M, Ilic A, Fine C, Sarvetnick N: Transforming growth factor-beta inhibits coxsackievirus-mediated autoimmune myocarditis. Viral Immunol 19:722-733, 2006
34. LaMarre J, Hayes MA, Wollenberg GK, Hussaini I, Hall SW, Gonias SL: An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice. J Clin Invest 87:39-44, 1991
35. Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM: CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 199:1467-1477, 2004
36. Masteller EL, Tang Q, Bluestone JA: Antigen-specific regulatory T cells: ex vivo expansion and therapeutic potential. Semin Immunol 18:103-110, 2006
37. Green EA, Choi Y, Flavell RA: Pancreatic lymph node-derived CD4(+ )CD25(+ ) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16:183-191, 2002
38. Bluestone JA, Tang Q: How do CD4+ CD25+ regulatory T cells control autoimmunity? Curr Opin Immunol 17:638-642, 2005
39. Tang Q, Adams JY, Tooley AJ, Bi M, Fife BT, Serra P, Santamaria P, Locksley RM, Krummel MF, Bluestone JA: Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 7:83-92, 2006
40. Weber MS, Prod'homme T, Youssef S, Dunn SE, Rundle CD, Lee L, Patarroyo JC, Stuve O, Sobel RA, Steinman L, Zamvil SS: Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat Med 13:935-943, 2007
41. Horwitz MS, Ilic A, Fine C, Balasa B, Sarvetnick N: Coxsackieviral- mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells. Clin Immunol 110:134-144, 2004
42. Yoon JW, Jun HS: Autoimmune destruction of pancreatic beta cells. Am J Ther 12:580-591, 2005
43. Bettelli E, Oukka M, Kuchroo VK: T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8:345-350, 2007
44. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT: Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123-1132, 2005
45. Selvaraj RK, Geiger TL: A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-p. J Immunol 178:7667-7677, 2007